New knowledge, new hopeNational Cancer Institute
Changing the face of cancerToday we are focusing on four areas of research: cancer biology, or how the disease works; blood cancers, such as leukemia; solid tumors, such as breast and prostate cancers; and cancer prevention and control.
- Prostate, breast and colon cancers
- Leukemia, lymphoma and gastrointestinal stromal tumors
- Cancer affecting other areas of the body
- Research led by an OHSU team established colonoscopy as the best way to detect colon cancer early.
- Dr. Brian Druker developed the world’s first drug to target the genetic defects of a particular cancer while leaving healthy cancer cells unharmed. Widely considered the beginning of the end of cancer as we know it, Gleevec has helped save tens of thousands of people with chronic myeloid leukemia around the world.
- In 2006, OHSU was one of 12 institutions to receive an award for Clinical and Translational Science from the U.S. National Institutes of Health for developing better cancer treatments.
How you can helpIf you are a patient, you may want to join a research study that will help others with cancer. Family members and friends can often participate in many studies, which need people without cancer to compare results. Learn more about clinical trials
We also need public and private support to achieve our goals. If you want to help us develop better cancer treatments -- and make Oregon the last place someone is likely to die from cancer - we invite you to join us. Help us achieve our goal.